secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001438133-22-000220
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes reports Q3 2022 results; financial details unavailable from filing excerpt
--------------------------------------------------------------------------------

- Tandem Diabetes issued a press release on November 2, 2022, covering Q3 2022 financial performance.
- No specific financial figures (revenue, EPS, guidance) were extractable from the provided filing text.
- Investors should refer to the full press release for detailed results and analysis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813322000220/0001438133-22-000220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813322000220/tndm-20221102.htm
  HTML page:      https://secwatch.observer/filing/0001438133-22-000220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer